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In regenerative concepts, the potential of adult stem cells holds great promise concerning an individu-
alized therapeutic approach. These cells provide renewable progenitor cells to replace aged tissue, and
play a signiﬁcant role in tissue repair and regeneration.
In this investigation, the characteristics of different types of adipose tissue are analysed systemati-
cally with special attention to their proliferation and differentiation potential concerning the angiogenic
and osteogenic lineage. Tissue samples from subcutaneous, visceral, and omental fat were processed
according to standard procedures. The cells were characterized and cultivated under suitable conditions
for osteogenic and angiogenic cell culture. The development of the different cell cultures as well as their
differentiation were analysed morphologically and immunohistochemically from cell passages P1 to P12.
Harvesting and isolation of multipotent cells from all three tissue types could be performed reproducibly.
The cultivation of these cells under osteogenic conditions led to a morphological and immunohisto-
chemical differentiation; mineralization could be detected. The most stable results were observed for the
cells of subcutaneous origin. An osteogenic differentiation from adipose-derived cells from all analysed
fatty tissues can be achieved easily and reproducibly. In therapeutic concepts including angiogenic
regeneration, adipose-derived cells from subcutaneous tissue provide the optimal cellular base.
© 2015. The Authors. Published by Elsevier Ltd on behalf of European Association for Cranio-Maxillo-
Facial Surgery. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Adult stem cells are detected in the human organism in different
regions such as the dental pulp, the liver, or various types of adipose
tissue (Gronthos et al., 2000; Palmer et al., 1997). The advantage of
these cells is their capacity to differentiate into various cells and
tissue types. Mesenchymal stem cells from the bone marrow are
able to develop into different cell types within the limits of their
original blastodermic layer, i.e. osteoblasts or chondrocytes. Mul-
tilineage developmental plasticity describes the stem cells' ability
to overcome the histological limitations of their initial germ layer
and their capacity to differentiate into progenitor cells and ulti-
mately into cell types of another origin (Keller, 2002). Cell-based
concepts are of increasing interest, especially in personalized
regenerative strategies. In different interventional approaches to
guided tissue regeneration, adult mesenchymal stem cells withxillofacial Surgery, University
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animal models of myocardial and cerebral ischaemic infarction, the
implantation of adipose-derived cells led to improved tissue repair
and functional regeneration (Schenke-Layland et al., 2009; Lee and
Yoon, 2008). For the regeneration of critical bone defects or bony
non-union after trauma, a combination of tissue engineering and
cell therapy including the use of mesenchymal stromal cells in an
autologous graft represents a promising possibility (Schubert et al.,
2013).
The growth of the nutrient vasculature parallel to the devel-
oping muscle or bone structures is an important issue in tissue
regeneration. An ideal cellular base for a personalized therapeutic
theory of tissue replacement or regeneration therefore should be
able to support the development not only of the severed tissue but
also the initiation of the committing vessel structures.
In personalized regenerative concepts, the multipotent cells
have to satisfy several conditions:
(1) The cells have to be able to support the regeneration of the
severed tissue, including its vasculature, effectively after
autologous transplantation.ion for Cranio-Maxillo-Facial Surgery. This is an open access article under the CC BY-
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and differentiation must be reproducible.
(3) The cells have to be easily accessible in certain amounts
without donor site morbidity.
For many years, bone marrow-derived mesenchymal stromal
cells (MSCs) have been considered the optimal cells for regenera-
tive purposes. A fatty tissue is another source of tissue-speciﬁc
stromal cells that comes with several advantages: compared to
other multipotent cells or endothelial progenitor cells, adipose-
derived cells occur in abundance and can be harvested in greater
volume. In addition, the cells proliferate without difﬁculty, expand
quickly in culture, and express their characteristic surface markers
over several passages, which indicate their stability and lasting
multipotency (Zuk et al., 2001, 2002). Human adipose-derived
stromal cells (hADSCs) are spindle-shaped cells localized in the
fatty tissues. Their harvesting and isolation can be easily performed
with a minimally invasive approach without tissue damage or
excessive scarring, for example by liposuction. These cells are
distinguished by their easy handling and their pronounced plas-
ticity. They are able to differentiate within their embryotic germ
layer to chondrocytes or myoblasts and across the cytological re-
strictions of the mesoderm to neuronal and endothelial cells
(Ashjian et al., 2003; Ning et al., 2009). These characteristics make
adipose-derived cells an ideal material for personalized regenera-
tive concepts including bone or chondral tissue. Adipose-derived
tissue represents an enormous reservoir of potentially angiogenic
cells. Their potential in therapeutic (neo-)vascularization is not yet
fully elucidated (Ouma et al., 2012; Sz€oke and Brinchmann, 2012).
During this investigation, we were able to isolate and cultivate
hADSC from three different types of adipose tissue samples. In all
three types, characteristic stem cell markers were expressed. It was
possible to induce osteogenic differentiation with expression of
osteoblast markers and mineralisation. It was possible also to
induce a differentiation across the original germ layers to endo-
thelial cells.
2. Material and Methods
2.1. Cell isolation and cultivation
2.1.1. Adipose-derived stromal cells (ADSC)
Human omental, visceral, and subcutaneous fat tissue was
collected under sterile conditions during elective abdominal sur-
gery, excluding oncological surgery, from the General and Visceral
Surgery, University Hospital, Münster (Germany). The samples
were collected anonymously from leftover tissue after patients
provided informed consent. The Ethics Committee of the medical
faculty approved the study.
The isolation and culture technique of Zuk et al. (2001) was
adopted. The tissue was minced and washed with phosphate-
buffered saline (PBS) (SigmaeAldrich Chemie GmbH, Germany)
for 10 min to reduce cellular debris and blood particles. This pro-
cedurewas repeated until no cellular debris or blood particles were
visible. The pieces were then digested with 0.1% collagenase (Bio-
chrom AG Seromed, Germany) in PBS for 60 min with gentle
agitation at 37 C. The suspension was ﬁltered through two nylon
meshes (Sefar AG, Switzerland) and centrifuged at 1200 g for 5 min.
The pellet was washed with 10 mL of PBS following centrifugation
and resuspended in minimum essential medium (Alpha Eagle [a-
MEM]; Lonza Walkersville, MD, USA) containing 10% foetal bovine
serum, 1% amphotericin B, 1% glutamine, 1% penicillin [10,000 U/
mL]/streptomycin [10,000 mg/mL] (Biochrom AG Seromed, Ger-
many) following centrifugation. For cell cultivation, cells were
cultured in a 90-mm culture dish for a period of 2 days at 37 Cwith5% CO2, then washed with PBS and fed with a-MEM. The cells were
fed every 2e3 days and passaged with 10,000 cells/cm2 every 5e7
days after reaching 90% of conﬂuence.
For estimation of the diameter of adherent cells, up to 55 cells
per passage were measured by means of measurement bars on
microscopic photos with Adobe Photoshop CS2 Version 9.0 (Adobe
Systems Inc., USA).
2.1.2. Osteogenic differentiation of hADSC
Cells of second passage were transferred to osteogenic medium:
a-MEM was replaced by High Growth Enhancement Medium
(HGEM) (ICN Biomedicals GmbH, Germany) without a-glycer-
ophosphate and ascorbic acid. Culture techniques were adopted of
Zuk et al. (2001). The medium was changed every 4e5 days. To
initiate mineralisation, HGEM was supplemented (HGEM(s)) with
10 mM a-glycerophosphate and 25 mg/mL ascorbic acid (Sigma,
Germany). Cells were cultivated at 37 C with 5% CO2. Mineralisa-
tion was visualized by Alizarin red staining.
2.1.3. Endothelial differentiation of hADSC
The cells of the second passage were transferred to an endo-
thelial medium. To stimulate endothelial differentiation, a-MEM
was replaced by endothelial cell growthmedium (EGM) (Promocell,
Heidelberg, Germany) and EGM 2 (Promocell, Heidelberg, Ger-
many). Cells were cultivated at 37 C with 5% CO2.
2.1.4. Human endothelial cells
Human umbilical cords were obtained by the Department of
Neonatology, University Hospital, Münster (Germany). After
washing umbilical cords in 70% ethanol, the umbilical vein was
rinsed with PBS (SigmaeAldrich Chemie GmbH, Germany). While
being occluded with arterial clips on both sides, the vein was ﬁlled
with PBS containing 0.05% collagenase (Biochrom AG Seromed,
Germany), and incubated for 10 min at 37 C. Cell suspension was
collected in a Falcon tube and centrifuged for 7 min at 1200 g. The
pellet was resuspended in EGM and plated in gelatine-coated 56.7-
cm2 culture dishes. Coatingwas prepared beforehand by incubating
dishes with 0.2% gelatin (SigmaeAldrich Chemie GmbH, Germany)
for at least 30 min at 37 C, followed by washing with PBS. Cells
were cultivated at 37 C with 5% CO2 while being fed every 3e4
days and passaged every 7e10 days after reaching nearly total
conﬂuence.
2.1.5. Human osteoblasts
Human spongiosa was obtained from Department of Craniofa-
cial Surgery, University Hospital, Münster (Germany). The tissue
was collected anonymously from leftover tissue after informed
consent of the patients. Pieces were washed several times with
HGEM and placed in a 90-mm culture dish in HGEM without a-
glycerophosphate and ascorbic acid at 37 C with 5% CO2. After 7
days bone pieces were removed. Mediumwas replaced every week,
containing 0.04% Fortecortin (Merck Pharma GmbH, Germany) for
osteogenic differentiation until growing cells reached 90% of
conﬂuence. Cells were passaged as described above.
2.1.6. Immunohistochemistry
Primary antibodies applied in this work: a-SMA (clone 1A4;
dilution 1:100; MP Biomedicals, USA), CD13 (cloneWM 15, dilution
1:25, Thermo Fischer Scientiﬁc, USA), CD31 (clone JC70A; dilution
1:100; Dako, Germany), CD44 (clone A3D8, dilution 1:50; Sigma
Aldrich, Germany), CD90 (clone AF-9; dilution 1:50; Thermo
Fischer Scientiﬁc, USA), collagen 1 (#ab6308, dilution 1:100;
abcam, England), osteocalcin (clone OC4-30; dilution 1:50; TaKaRa,
Japan), osteonectin (OSN4-2; dilution 1:50, TaKaRa, Japan), and
vWF (#F3520, dilution 1:100, Sigma Aldrich, Germany). Other than
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mice. vWF is a polyclonal antibody from rabbits. Secondary anti-
bodies were Alexa Fluor 488 goat anti-mouse (dilution 1:100;
Invitrogen, USA) and in case of vWF Alexa Fluor 488 anti-rabbit
(dilution 1:100; Invitrogen, USA). Staining protocols performed
according to the manufacturer's protocols. Stained cells examined
with the ﬂuorescence microscope Axioplan 2 (Carl Zeiss, Germany).
Negative as well as positive controls were implemented according
to manufacturer's protocols.
2.1.7. Alizarin Red staining
For detection of calciﬁcation during osteogenic differentiation,
the induced cells were rinsed twice with PBS and ﬁxed with meth-
anol for 20 min. The ﬁxed cells were stained with 1 mL of Alizarin
Red solution (Chroma-Gesellschaft mBH & Co., Germany/Carl Roth
GmbH & Co. KG, Germany) and incubated for 2 min at room tem-
perature. Cells culture in HGEM was used as negative control.
3. Results
3.1. Cell morphology
Human adipose-derived stromal cells show a spindle-cell-like
bipolar morphology. By comparison, there are morphological dif-
ferences in cell structure among cells isolated from subcutaneous
(Fig. 1), visceral (Fig. 2), and omental (Fig. 3) adipose tissue. Cells of
subcutaneous preparations have a mean diameter of 133.5 mmFig. 1. Human subcutaneous fat tissue-derived cells(adherent) in passage 1 (Table 1). The diameter increases in further
passages, depending on primary cell density. Although cell density
declines in further passages, the complete population upholds its
homogeneity.
Preparations of human visceral adipose tissue show a more
heterogeneous cellular architecture. It also has a bipolar
morphology, but in comparison with subcutaneous preparations,
cells appear more voluminous and tend to build ramiﬁed cell
junctions. The diameter varies considerably between lower (P1:
49.6 mm) and higher (P3: 338.9 mm) passages (Table 1). Visceral
adipose tissue preparations can be processed analogously; the
cultures are marked by contaminating cells, especially spindle-
shaped ﬁbroblasts or cobblestone-like mesothelial cells. Meso-
thelial cells have a polygonal shape with deep blue cytoplasm
and clearly visible nuclei, appearing as part of small insular
clusters, especially in lower passages. However, their survival
seems to be transient: within a few days these cells tend to
hypertrophy, including embedding of vesicles and ﬁnally decay
(Fig. 2).
Different cell types are found in human omental adipose tissue
preparations, mainly mesothelial cells and only a few visceral-type
ADSC (Fig. 3). Due to the short survival of these cells, the pre-
dominating cell type switches during passages 4 and 5 to visceral-
type ADSC, which show similar characteristics compared to sub-
cutaneously or viscerally derived preparations. This majority
switch is also visible in the sudden increase of cell diameter be-
tween these passages (Table 1).in culture, passages P1eP12, 10 magniﬁcation.
Fig. 2. Human visceral fat tissue-derived cells in culture, passages P1eP12, 10 magniﬁcation.
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Spindle-shaped cells from subcutaneous, visceral, and omental
preparations express CD13, CD44, and CD90 in all cultivated pas-
sages with similar intensity; the expression of CD44 is more
intense. The endothelial antigen vWF can also be detected from
passage 1 to 12, whereas the expression of CD31 is absent. a-SMA is
also expressed by the cells from passages 1 to 12 (Fig. 4).
Mesothelial cells, derived from omental adipose tissue, also
express CD13, CD44, and CD90, comparable to multipotent cells.
These cells also express vWF with high intensity (Fig. 4).
3.3. Osteogenic differentiation
Fig. 5 shows the immunohistochemical analysis according to
osteogenic differentiation. The staining of the adipose-derived cells
is correlated with human osteoblasts as a control group. Within 10
days in HGEM, cells derived from subcutaneous, visceral, and
omental tissue change their morphology towards a more
osteoblast-like shape: The width doubles, length decreases, cell
nucleus becomes larger, and the culture condenses (Fig. 5). The
mean cell diameter is 19.7 mm. Subcutaneous cells differentiates
faster than visceral or omental cells. Visceral and omental adipose
tissue cell cultures need more time for the differentiating process
because of contaminating mesothelial cells, which cause the cul-
tures to remain inhomogeneous for several weeks. Omental tissue-
derived cell cultures tend to decease after a few weeks.HGEM supplemented with a-glycerophosphate and ascorbic
acid accelerates the differentiation process in all cell lineages, also
in visceral and omental fat tissue cultures. The extrinsic cells such
as ﬁbroblasts or mesothelial cells decay within 10e30 days.
The immunophenotype of differentiated adipose-derived cells
correlates with human osteoblasts: The proteins osteocalcin,
osteonectin, and collagen I are expressed (Fig. 5). Subcutaneous
tissue-derived cells, as compared with visceral- or even omental
tissue-derived cells, show a high intensity of protein expression,
depending on the amount of differentiated cells in culture (Fig. 5).
In visceral- and omental tissue-derived cell cultures, cobblestone-
like mesothelial cells express the antigens as well, which suggests
an osteogenic differentiating potential. A culturing time of about
approximately 40 days in HGEM including supplement leads to
mineralisation of all cell lineages indicated by positive Alizarin red
staining (Fig. 5).
3.4. Endothelial differentiation
After 2 days of cultivation, the cells start to proliferate quickly.
Cell growth increases while using EGM2. Subcutaneous tissue-
derived cell cultures become conﬂuent within 3e5 days as opposed
to 7e10 days using EGM. Comparable to osteogenic differentiation,
visceral- and omental tissue-derived cells needed more time to
express endothelial characteristics. Differentiated cells are small
and spindle-shaped, containing a large cell nucleus; the mean
diameter of detached cells is 16.5 mm.
Fig. 3. Human omental fat tissue-derived cells in culture, passages P1eP12, 10 magniﬁcation.
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endothelial differentiation. The staining of the adipose tissue-
derived cells is correlated with human endothelial cells as a control
group. In the immunohistochemical analysis, the differentiated
cells of all tissues express vWF, which is less marked while using
EGM instead of EGM2. The expression of CD31 is detectable only on
differentiated cells from subcutaneous- and visceral tissue-derivedTable 1
Mean diameter of adherent cells derived from subcutaneous, visceral, and omental
fat tissue per passage growth in a-MEM.
Passage Subcutaneous Visceral Omental
Mean
diameter
(mm)
SD
(mm)
Mean
diameter
(mm)
SD
(mm)
Mean
diameter
(mm)
SD
(mm)
P0 132.180 24.168 129.920 33.383 41.190 12.914
P1 131.620 27.001 151.420 45.551 45.530 28.934
P2 139.220 35.536 168.400 38.068 74.260 29.417
P3 133.415 37.420 171.230 54.398 70.610 20.023
P4 134.820 32.293 172.840 52.389 74.000 21.558
P5 129.415 34.585 174.610 36.402 110.255 27.762
P6 128.705 33.843 159.980 48.834 121.550 38.791
P7 130.830 35.773 172.450 41.295 133.510 36.228
P8 126.310 39.990 150.870 39.344 148.360 37.603
P9 128.250 42.745 161.410 35.814 139.930 30.520
P10 149.030 40.855 152.240 40.652 145.340 39.158
P11 133.970 40.338 166.290 48.117 162.250 38.000
P12 137.930 41.028 171.250 35.820 177.800 38.632tissues using EGM2. Nevertheless, the antigen is expressed on
fewer cells and shows a more spindle-shaped structure, compared
to the reticular structure of the marked cell junctions of human
endothelial cells (Fig. 6).4. Discussion
In the present study, the isolation, cultivation, and induction
towards osteogenic and angiogenic differentiation from cells
derived by miscellaneous adipose tissue is discussed. One purpose
of this work is to determine whether all types of adipose tissue can
be used from donor sites for the isolation of mesenchymal stromal
cells, and also whether the characteristic surface markers are
expressed equally.
Adipose tissues are a rich source of multipotent adult cells. Not
only the cells harvested as by-products after liposuction, but also
cells dissected and harvested during standard surgical procedures
from visceral or omental adipose tissue might provide multipotent
cells for autologous regenerative purposes.
Lipoaspirate samples provide the advantage of gaining a large
amount of cells during the standard surgical procedure. It is not
possible, however, to purposely omit areas containing vascular
structures or ﬁbroblast-rich connective tissue to provide a more
homogeneous cell culture without contamination. By leading the
needle subcutaneously, optical control is not feasible. By selectively
dissecting the fat tissue, a contamination at least of macroscopically
recognisable different cell types is possible and may lead to a more
Fig. 4. Expression of ADSC marker CD13, CD44, CD90, a-SMA, and endothelial markers
vWF and CD31 on human subcutaneous-, visceral-, and omental fat tissue-derived
cells.
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thelial cells in the omental and visceral cell cultures that have been
dissected under visual control contradicts this hypothesis, however.
The observed decay of the additional cells without weakening the
culture results leads to the assumption that a contamination with
mesothelial cells has no adverse effect on cell proliferation and
differentiation.
Toyoda et al. compared the characteristics of omental and sub-
cutaneous fat and concluded that there are no differences con-
cerning either the amount of cells or their proliferation (Toyoda
et al., 2009). Due to the high density of endothelial progenitor
cells in the subcutaneous tissue, the angiogenic differentiation is
more successful as compared to omental tissue. These ﬁndings are
underlined by the study at hand (Toyoda et al., 2009). The capability
of osteogenic differentiation seems to be more pronounced in
multipotent cells from abdominal adipose tissue; this observation
might be related to the respective culture conditions. In the direct
comparison of identical cultural conditions of this investigation, no
advantage of the omental cells was observed.
Morphologically, the cells from different origins are comparable.
Zuk et al. describe the morphological appearance of these isolated
cells as being similar to ﬁbroblasts and resembling bone marrow-derived mesenchymal stem cells (Zuk et al., 2001). Multipotent
cells from donor sites other than the bone marrow emerge as
ﬁbroblast-like spindle-shaped cells (Ashjian et al., 2003). The sub-
cutaneous cells in this study, harvested by tissue resection during
general surgery, match these morphological characteristics. Alter-
native donor regions as omental or visceral fat tissue are less
prominent and not as well investigated. Sachs et al. studied adi-
pose-derived multipotent cells from visceral fat and described
comparable morphological, immunohistochemical, and multi-
potent features as in subcutaneous fat cells (Sachs et al., 2012).
When dealing with these cells, the crucial ﬁrst task is to clearly
deﬁne the investigated cells at hand clearly as multipotent
mesenchymal cells and to differentiate them from nearly ubiqui-
tous ﬁbroblasts or leukocytes. The mesenchymal stromal cells are
characterised immunohistochemically by different surface
markers; the most prominent are CD13, alanyl aminopeptidase N,
expressed especially in endothelial cells of the intestines, CD44, a
surface marker and collagen receptor, and CD90, an essential
glycoprotein with substantial importance in cellecell adhesion and
neuronal growth (Jones et al., 2002; Dimitroff et al., 2001; Saalbach
et al., 2000; Mitchell et al., 2006).
In the characterisation of adipose tissueederived multipotent
cells, the overexpression of CD13, CD44, and CD90 among others
proved to be the most pronounced and therefore characteristic of
the studied cells (Zuk et al., 2002). Another relevant marker is
aesmooth muscle actin (a-SMA), an intracellular contractile
structural ﬁlament of the cytoskeleton. It is expressed in smooth
muscle cells or myoﬁbroblasts. Its presence represents a negative
control for endothelial cells. a-SMA is transitorily expressed by a
variety of mesodermally derived cells during their proliferation and
development or in processes of tissue repair (Liu et al., 2013). The
presence of a-SMA as hADSC marker has already been described in
the literature (Cheng et al., 2011). In addition to morphological
examination, characterisation by deﬁned surface marker stands for
the unambiguous identiﬁcation of the studied cells and traces their
development. The selected surface markers in the present investi-
gation were CD13, CD44, and CD90 and a-SMA. The absence of
CD31 ruled out the presence of a mature endothelial culture.
In the current literature, a plethora of relevant surface markers
to conﬁrm the identity of the studied, allegedly multipotent cells
are discussed: the experimental proof of CD105, CD73, or CD90
combined with the lack of CD14, CD45, or c-kit substantiate the
identity of the MSCs (Kuhbier et al., 2010). CD44 and CD90 have
been described as surface markers of adipose derived cells from
subcutaneous and omental origin. CD90 seems to be expressed
more strongly than on cells from visceral origin (Baglioni et al.,
2009; Klopp et al., 2012). Festy et al. observed CD13 as a strong
indicator for subcutaneous as well as visceral derived multipotent
cells; CD13 therefore was chosen for the study at hand (Festy et al.,
2005). The aim of this characterisation is to be sure to avoid ﬁ-
broblasts, endothelial cells, and leukocytes. In the present study,
the combination of cell harvesting and preparation, the conﬁrma-
tion of selected surface markers, and the morphologic analysis
accounts for the identity of adipose tissue-derived multipotent
cells. Considering the strong similarity to ﬁbroblasts, the ability to
differentiate ﬁnally reveals the multipotent cells (Alipour et al.,
2010; Yu et al., 2010). One crucial ﬁnding of this investigation was
the reproducible osteogenic differentiation in all studied cell line-
ages. This result might be of some relevance in the development of
autologous regenerative therapy concepts of bony critical-sized
defects or non-unions following trauma or tumour resections.
Schubert at al. introduced an autologous graft consisting of a 3D
scaffold of demineralised bone matrix and autologous subcutane-
ous fat cells in a minipig model, and were able to show increased
bone formation in a spine fusion model as well as a critical-sized
Fig. 5. Expression of osteoblastic markers osteocalcin, osteonectin, collagen I on subcutaneous-, visceral-, and omental fat tissue-derived cells in HGEM and supplemented HGEM
undergoing osteogenesis compared to human osteoblasts. The differentiation process of subcutaneous preparations shows the best result in cell density, homogeneity, and protein
expression. A positive mineralisation is visible in all lineages after 40 days of culture with HGEM(s), supplemented with a-glycerophosphate 10 mM (Sigma, Germany) and L-ascorbic
acid 25 mg/mL (Sigma, Germany).
Fig. 6. Expression of endothelial markers CD31 and vWF on subcutaneous-, visceral-, and omental fat tissue-derived cells in EGM and EGM2 undergoing angiogenesis compared to
HUVECs. In general there is a difference in cell morphology and protein expression on fat tissue cells compared to endothelial cells. The differentiation process of subcutaneous
preparations shows the best result in cell density and homogeneity. The expression of vWF is detectable on cells of all cultures. CD31 is visible on differentiated subcutaneous- and
visceral fat tissue-derived cells using EGM2.
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ﬁndings, visceral and omental multipotent cells can be considered
as a potential cell base as well. The regulation of the differentiation
seems to stand under the regulation of miRNA: Li et al. observed
adipogenic and osteogenic differentiation of MSCs from lip-
oaspirates with respect to the aspect of miRNA-dependentregulation: Generally the harvested cells hold the potential for
adipogenic and osteogenic differentiation. The regulation of which
cell type emerges is governed by miRNA expression: Whereas an
overexpression of certain miRNAs induces adipogenic differentia-
tion, their inhibition supports osteogenic differentiation (Li et al.,
2013). The angiogenic differentiation in this setting has not been
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models, adipose-derived cells in EGM2 medium show the typical
endothelial morphology and express the characteristic surface
markers CD31 and vWF after two weeks (Ning et al., 2009; Konno
et al., 2010). During the investigation at hand, using human cells,
the immunohistochemical markers were not as strongly expressed.
Especially, stromal cells from the omental tissue are less able to
perform endothelial differentiation and do not express CD31 in this
study concept.
Several key factors for endothelial differentiation have been
discussed. The presence of CD34 and the application of VEGF or
culture condition using shear stress are studied and seem to favour
endothelial differentiation, but not all critical factors are yet un-
derstood (Marino et al., 2012; Fischer et al., 2009; Colazzo et al.,
2011).
Regarding a developing vasculature, the optimal adipose-
derived cellular source for regenerative purposes are subcutane-
ous cells.
5. Conclusion
This study setup aims to systematically analyse different types
of adipose tissue with special regard to their proliferation and
differentiation potential concerning the angiogenic and osteogenic
lineage. The cultivation of subcutaneous, visceral, and omental fat
cells under osteogenic conditions led to a morphological and
immunohistochemical differentiation; mineralization could be
detected, most reliably for the cells of subcutaneous origin. An
osteogenic differentiation from adipose derived cells from all ana-
lysed fatty tissues can be achieved easily and reproducibly.
In therapeutic concepts including angiogenic regeneration,
adipose-derived cells from subcutaneous tissue provide the
optimal cellular base, even if the immunohistochemical analysis
provided less pronounced results of endothelial differentiation
compared to osteogenic differentiation.
The ﬁndings of this investigation provide the basis for more
speciﬁc analysis of the different multipotent adipose tissue-derived
cells, and might improve existing concepts of hADSs-related indi-
vidualized regenerative therapies.
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